702 King Farm Blvd., Suite 200,
Rockville , MD, 20850
Rockville , MD, 20850
Summary
The fund seeks capital appreciation by investing in small-and mid-size companies in the United States.
The investment process is designed to highlight companies that are engaged in the health care industry.
The investment team considers pharmaceutical companies, companies involved in the research and development of pharmaceutical products and services, companies involved in the operation of health care facilities as related More
Link
Directors
Jun 13, 2023- Randall C. Barnes
- Sandra G. Sponem
- Ronald E. Toupin, Jr.
- Angela Brock-Kyle
- Thomas F. Lydon Jr.
- Amy J. Lee
- Ronald A. Nyberg
Chief Compliance Officer
- Elisabeth Miller
Fund Manager(s)
- Michael Byrum
- Ryan Harder
Price
- 52-Week High/Low
- $45.81 - $39.33
- Turnover
- 341%
- Expense Ratio
- 1.39%
Company Name |
Holding |
| Eli Lilly & Co | 3.8 % |
| UnitedHealth Group Inc | 3 % |
| Johnson & Johnson | 2.55 % |
| AbbVie Inc | 2.38 % |
| Merck & Co Inc | 2.35 % |
| Thermo Fisher Scientific Inc | 1.94 % |
| Abbott Laboratories | 1.82 % |
| Amgen Inc | 1.8 % |
| Danaher Corp | 1.77 % |
| Intuitive Surgical Inc | 1.74 % |
| More | 1.74 % |
Documents
Performance
YTD
-
3 Year
-3.27%
5 Year
20.31%
Best
42.29%
2013
Worst
-24.7%
2008
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | 7.2% | -0.4% | -6.2% | -1.1% | -13.9% | 11.9% | 0.8% | 9.7% | -9.7% |
| Q2 | - | -5.3% | 2.6% | -10.7% | 13.5% | 18.7% | 0.6% | 8.6% | 8.5% | 3.7% |
| Q3 | - | - | -4.5% | -5.8% | -2.6% | -2.7% | -5% | 10.9% | 1.9% | 3.7% |
| Q4 | - | - | 8.9% | 10.2% | 5.5% | 9.8% | 14% | -14.3% | 0.7% | -6.6% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | 1.5% | 3.1% | 2.4% | -6.8% | - | - | - | - | - | - | - | - |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 5% | 6% | -13% | 15% | 9% | 23% | 2% | 24% | -9% |
Alpha
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| RYHIX | - | 5% | 6% | -13% | 15% | 9% | 23% | 2% | 24% | -9% |
| S&P 500 | - | - | - | -21% | 27% | 16% | 29% | -6% | 19% | 10% |
| Alpha | - | 5% | 6% | 8% | -11% | -7% | -6% | 8% | 4% | -19% |